Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Cablivi. Always confirm against the full prescribing information.
100 interactions
Aceclofenac
The risk or severity of bleeding can be increased when Aceclofenac is combined with Caplacizumab.
Level 1 evidence
Acenocoumarol
The risk or severity of bleeding can be increased when Caplacizumab is combined with Acenocoumarol.
Level 1 evidence
Acetylsalicylic acid
Acetylsalicylic acid may increase the antiplatelet activities of Caplacizumab.
Level 1 evidence
Alteplase
The risk or severity of bleeding can be increased when Caplacizumab is combined with Alteplase.
Level 1 evidence
Aminosalicylic acid
The risk or severity of bleeding can be increased when Caplacizumab is combined with Aminosalicylic acid.
Level 2 evidence
Anagrelide
Anagrelide may increase the antiplatelet activities of Caplacizumab.
Level 2 evidence
Antipyrine
The risk or severity of bleeding can be increased when Antipyrine is combined with Caplacizumab.
Level 1 evidence
Antithrombin Alfa
The risk or severity of bleeding can be increased when Caplacizumab is combined with Antithrombin Alfa.
Level 1 evidence
Antithrombin III human
The risk or severity of bleeding can be increased when Caplacizumab is combined with Antithrombin III human.
Level 1 evidence
Apixaban
The risk or severity of adverse effects can be increased when Caplacizumab is combined with Apixaban.
Level 1 evidence
Argatroban
The risk or severity of bleeding can be increased when Caplacizumab is combined with Argatroban.
Level 1 evidence
Astaxanthin
The risk or severity of bleeding can be increased when Caplacizumab is combined with Astaxanthin.
Level 1 evidence
Enter your NPI to unlock 1 major interaction for Cablivi
Cablivi (Caplacizumab) has 384 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Cablivi (Caplacizumab) has 1 major, 125 moderate, and 258 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Cablivi. Always confirm against the full prescribing information.